236 related articles for article (PubMed ID: 18090923)
41. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
[TBL] [Abstract][Full Text] [Related]
42. Transferrin localizes in Bunina bodies in amyotrophic lateral sclerosis.
Mizuno Y; Amari M; Takatama M; Aizawa H; Mihara B; Okamoto K
Acta Neuropathol; 2006 Nov; 112(5):597-603. PubMed ID: 16896902
[TBL] [Abstract][Full Text] [Related]
43. TDP-43 and FUS: a nuclear affair.
Dormann D; Haass C
Trends Neurosci; 2011 Jul; 34(7):339-48. PubMed ID: 21700347
[TBL] [Abstract][Full Text] [Related]
44. Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC).
Miklossy J; Steele JC; Yu S; McCall S; Sandberg G; McGeer EG; McGeer PL
Acta Neuropathol; 2008 Dec; 116(6):625-37. PubMed ID: 18843496
[TBL] [Abstract][Full Text] [Related]
45. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
[TBL] [Abstract][Full Text] [Related]
46. Autophagy Is a Common Degradation Pathway for Bunina Bodies and TDP-43 Inclusions in Amyotrophic Lateral Sclerosis.
Mori F; Miki Y; Kon T; Tanji K; Wakabayashi K
J Neuropathol Exp Neurol; 2019 Oct; 78(10):910-921. PubMed ID: 31504678
[TBL] [Abstract][Full Text] [Related]
47. Accumulation of Nonfibrillar TDP-43 in the Rough Endoplasmic Reticulum Is the Early-Stage Pathology in Amyotrophic Lateral Sclerosis.
Kon T; Mori F; Tanji K; Miki Y; Nishijima H; Nakamura T; Kinoshita I; Suzuki C; Kurotaki H; Tomiyama M; Wakabayashi K
J Neuropathol Exp Neurol; 2022 Mar; 81(4):271-281. PubMed ID: 35294549
[TBL] [Abstract][Full Text] [Related]
48. Rho guanine nucleotide exchange factor is an NFL mRNA destabilizing factor that forms cytoplasmic inclusions in amyotrophic lateral sclerosis.
Droppelmann CA; Keller BA; Campos-Melo D; Volkening K; Strong MJ
Neurobiol Aging; 2013 Jan; 34(1):248-62. PubMed ID: 22835604
[TBL] [Abstract][Full Text] [Related]
49. Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation.
Ito H; Nakamura M; Komure O; Ayaki T; Wate R; Maruyama H; Nakamura Y; Fujita K; Kaneko S; Okamoto Y; Ihara M; Konishi T; Ogasawara K; Hirano A; Kusaka H; Kaji R; Takahashi R; Kawakami H
Acta Neuropathol; 2011 Aug; 122(2):223-9. PubMed ID: 21644038
[TBL] [Abstract][Full Text] [Related]
50. Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease.
Schwab C; Arai T; Hasegawa M; Yu S; McGeer PL
J Neuropathol Exp Neurol; 2008 Dec; 67(12):1159-65. PubMed ID: 19018245
[TBL] [Abstract][Full Text] [Related]
51. Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice.
Wu LS; Cheng WC; Shen CK
J Biol Chem; 2012 Aug; 287(33):27335-44. PubMed ID: 22718760
[TBL] [Abstract][Full Text] [Related]
52. [Molecular Pathogenesis of Amyotrophic Lateral Sclerosis].
Tsuboguchi S; Ishihara T; Sugai A; Yokoseki A; Onodera O
Brain Nerve; 2019 Nov; 71(11):1183-1189. PubMed ID: 31722304
[TBL] [Abstract][Full Text] [Related]
53. Clinical and pathological continuum of multisystem TDP-43 proteinopathies.
Geser F; Martinez-Lage M; Robinson J; Uryu K; Neumann M; Brandmeir NJ; Xie SX; Kwong LK; Elman L; McCluskey L; Clark CM; Malunda J; Miller BL; Zimmerman EA; Qian J; Van Deerlin V; Grossman M; Lee VM; Trojanowski JQ
Arch Neurol; 2009 Feb; 66(2):180-9. PubMed ID: 19204154
[TBL] [Abstract][Full Text] [Related]
54. TDP-43: a novel neurodegenerative proteinopathy.
Forman MS; Trojanowski JQ; Lee VM
Curr Opin Neurobiol; 2007 Oct; 17(5):548-55. PubMed ID: 17936612
[TBL] [Abstract][Full Text] [Related]
55. TDP-43 pathology in polyglutamine diseases: with reference to amyotrphic lateral sclerosis.
Toyoshima Y; Takahashi H
Neuropathology; 2014 Feb; 34(1):77-82. PubMed ID: 23889603
[TBL] [Abstract][Full Text] [Related]
56. Accumulation of phosphorylated TDP-43 in the cytoplasm of Schwann cells in a case of sporadic amyotrophic lateral sclerosis.
Nakamura-Shindo K; Sakai K; Shimizu A; Ishida C; Yamada M
Neuropathology; 2020 Dec; 40(6):606-610. PubMed ID: 32776323
[TBL] [Abstract][Full Text] [Related]
57. Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations.
De Marco G; Lupino E; Calvo A; Moglia C; Buccinnà B; Grifoni S; Ramondetti C; Lomartire A; Rinaudo MT; Piccinini M; Giordana MT; Chiò A
Acta Neuropathol; 2011 May; 121(5):611-22. PubMed ID: 21120508
[TBL] [Abstract][Full Text] [Related]
58. Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43.
Watanabe S; Inami H; Oiwa K; Murata Y; Sakai S; Komine O; Sobue A; Iguchi Y; Katsuno M; Yamanaka K
Cell Death Dis; 2020 Oct; 11(10):909. PubMed ID: 33097688
[TBL] [Abstract][Full Text] [Related]
59. Cytoplasmic TDP-43 accumulation in cells of the adrenal medulla in individuals with or without amyotrophic lateral sclerosis.
Okamoto K; Amari M; Fujita Y; Makioka K; Fukuda T; Suzuki K; Takatama M
Neuropathology; 2014 Dec; 34(6):535-40. PubMed ID: 25039310
[TBL] [Abstract][Full Text] [Related]
60. Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis.
Sasaki S
J Neuropathol Exp Neurol; 2011 May; 70(5):349-59. PubMed ID: 21487309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
